Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Pantumor MRD-studie

22. september 2026 oppdatert av: Paradigm Health

Molecular Residual Disease in Solid Tumors: En prospektiv studie for å samle inn kliniske data og bioprøver for å støtte oppdagelse og utvikling av kreftbiomarkører

The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, for example, to improve cancer detection and to assess the risk of cancer coming back.

Participants will receive routine standard of care from their doctor and their involvement is expected to last for approximately five and a half (5.5) years.

Studieoversikt

Studietype

Observasjonsmessig

Registrering (Antatt)

1350

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forente stater, 35205
    • Arizona
      • Bullhead City, Arizona, Forente stater, 86442
        • Rekruttering
        • Mohtaseb Cancer Center and Blood Disorders
        • Hovedetterforsker:
          • Hamdy Mohtaseb
        • Ta kontakt med:
      • Casa Grande, Arizona, Forente stater, 85122
        • Rekruttering
        • Cancer & Blood Specialists of Arizona
        • Ta kontakt med:
        • Hovedetterforsker:
          • Carlos Arce-Lara
    • Arkansas
      • Little Rock, Arkansas, Forente stater, 72205
        • Rekruttering
        • CARTI
        • Ta kontakt med:
        • Hovedetterforsker:
          • Andrew Briggler
      • Springdale, Arkansas, Forente stater, 72762
        • Rekruttering
        • Highlands Oncology Group (HOG)
        • Hovedetterforsker:
          • Joseph Beck
        • Ta kontakt med:
    • California
      • Glendale, California, Forente stater, 91204
        • Rekruttering
        • Los Angeles Cancer Network (LACN)
        • Ta kontakt med:
        • Hovedetterforsker:
          • Peyman Salimi-Tari
      • Oxnard, California, Forente stater, 93030
        • Rekruttering
        • Ventura County Hematology Oncology Specialists
        • Ta kontakt med:
        • Hovedetterforsker:
          • Lynn Kong
      • San Diego, California, Forente stater, 92123
      • San Diego, California, Forente stater, 92123
        • Rekruttering
        • Medical Oncology Associates of San Diego (MOASD)
        • Ta kontakt med:
        • Hovedetterforsker:
          • James Coggan
      • Stockton, California, Forente stater, 95204
        • Rekruttering
        • Stockton Hematology Oncology Med Group
        • Ta kontakt med:
        • Hovedetterforsker:
          • Sunny Phillip
    • Colorado
      • Englewood, Colorado, Forente stater, 80113
        • Rekruttering
        • The Melanoma and Skin Cancer Institute
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ryan Weight
    • Florida
      • Coral Springs, Florida, Forente stater, 33065
        • Rekruttering
        • Oncology & Hematology Associates of West Broward
        • Hovedetterforsker:
          • Sumit Sawhney
        • Ta kontakt med:
      • Orange City, Florida, Forente stater, 32763
        • Rekruttering
        • Mid Florida Cancer Centers
        • Hovedetterforsker:
          • Santosh Nair
        • Ta kontakt med:
      • St. Petersburg, Florida, Forente stater, 33709
        • Rekruttering
        • Comprehensive Hematology Oncology (CHO)
        • Hovedetterforsker:
          • Neeharika Makani
        • Ta kontakt med:
    • Georgia
      • Atlanta, Georgia, Forente stater, 30318
        • Rekruttering
        • Piedmont Cancer Institute
        • Ta kontakt med:
        • Hovedetterforsker:
          • Vasileios Assikis
    • Illinois
      • O'Fallon, Illinois, Forente stater, 62269
        • Rekruttering
        • Cancer Care Specialists of Illinois (CCSI)
        • Hovedetterforsker:
          • James Wade
        • Ta kontakt med:
      • Urbana, Illinois, Forente stater, 61801
        • Rekruttering
        • Carle Health
        • Ta kontakt med:
        • Hovedetterforsker:
          • Christine Canfield
    • Kansas
      • Topeka, Kansas, Forente stater, 66606
        • Rekruttering
        • Cotton O'Neil Cancer Center [Stormont Vail]
        • Ta kontakt med:
        • Hovedetterforsker:
          • Mehmmod Hashmi
      • Wichita, Kansas, Forente stater, 67214
    • Kentucky
      • Corbin, Kentucky, Forente stater, 40701
        • Rekruttering
        • Baptist Health Corbin
        • Ta kontakt med:
        • Hovedetterforsker:
          • Abigail Byrnes
      • Elizabethtown, Kentucky, Forente stater, 42701
        • Rekruttering
        • Baptist Health Hardin
        • Ta kontakt med:
        • Hovedetterforsker:
          • Christopher Burkeen
      • Lexington, Kentucky, Forente stater, 40503
        • Rekruttering
        • Baptist Health Lexington
        • Hovedetterforsker:
          • Arvinda Padmanabhan
        • Ta kontakt med:
      • Louisville, Kentucky, Forente stater, 40207
        • Rekruttering
        • Baptist Health Louisville
        • Hovedetterforsker:
          • Wangjian Zhong
        • Ta kontakt med:
    • Louisiana
      • Covington, Louisiana, Forente stater, 70433
        • Rekruttering
        • Pontchartrain Cancer Center
        • Hovedetterforsker:
          • David Oubre
        • Ta kontakt med:
      • Shreveport, Louisiana, Forente stater, 71105
        • Rekruttering
        • Christus Health Highlands
        • Ta kontakt med:
        • Hovedetterforsker:
          • Neelima Chintapalli
    • Michigan
      • Grand Rapids, Michigan, Forente stater, 49546
        • Rekruttering
        • The Cancer & Hematology Centers (CHC)
        • Ta kontakt med:
        • Hovedetterforsker:
          • Joy Bartholomew
    • Minnesota
      • Rochester, Minnesota, Forente stater, 55905
        • Rekruttering
        • Mayo Clinic
        • Ta kontakt med:
        • Hovedetterforsker:
          • Lisa Boardman
    • Missouri
      • Springfield, Missouri, Forente stater, 65807
        • Rekruttering
        • Cox Health
        • Ta kontakt med:
        • Hovedetterforsker:
          • Rajesh Banderudrappagari
    • Nebraska
      • Lincoln, Nebraska, Forente stater, 68516
        • Rekruttering
        • Cancer Partners of Nebraska
        • Ta kontakt med:
        • Hovedetterforsker:
          • Stacey Knox
    • New Mexico
      • Farmington, New Mexico, Forente stater, 87401
        • Rekruttering
        • San Juan Oncology Associates
        • Hovedetterforsker:
          • Sardar Imam
        • Ta kontakt med:
    • New York
      • Binghamton, New York, Forente stater, 13905
        • Rekruttering
        • Guthrie Lourdes Memorial Hospital (GLMH)
        • Hovedetterforsker:
          • Beka Aroshidze
        • Ta kontakt med:
      • Shirley, New York, Forente stater, 11967
        • Rekruttering
        • New York Cancer & Blood Specialists
        • Hovedetterforsker:
          • Richard Zuniga
        • Ta kontakt med:
    • North Carolina
      • Charlotte, North Carolina, Forente stater, 28207
        • Rekruttering
        • Carolina Oncology Specialists
        • Hovedetterforsker:
          • Justin Favaro
        • Ta kontakt med:
      • Goldsboro, North Carolina, Forente stater, 27534
        • Rekruttering
        • Southeastern Medical Oncology Center (SMOC)
        • Ta kontakt med:
        • Hovedetterforsker:
          • Samer Kasbari
      • Wilson, North Carolina, Forente stater, 27893
        • Rekruttering
        • Regional Medical Oncology Center
        • Hovedetterforsker:
          • Keith Lerro
        • Ta kontakt med:
    • Ohio
      • Canton, Ohio, Forente stater, 44718
        • Rekruttering
        • Gabrail Cancer Center
        • Hovedetterforsker:
          • Nashat Gabrail
        • Ta kontakt med:
      • Maumee, Ohio, Forente stater, 43437
        • Rekruttering
        • Taylor Cancer Research Center
        • Ta kontakt med:
    • Oklahoma
      • Tulsa, Oklahoma, Forente stater, 74129
        • Rekruttering
        • Oklahoma Cancer Specialists and Research Institute (OCSRI)
        • Ta kontakt med:
        • Hovedetterforsker:
          • Scott Cole
    • Oregon
      • Portland, Oregon, Forente stater, 97201
        • Rekruttering
        • Oregon Health & Science University (OHSU)
        • Hovedetterforsker:
          • Nima Nabavizadeh
        • Ta kontakt med:
    • Pennsylvania
      • Lancaster, Pennsylvania, Forente stater, 17601
        • Rekruttering
        • Lancaster General Hospital (UPenn)
        • Ta kontakt med:
        • Hovedetterforsker:
          • Efrat Dotan
      • Sayre, Pennsylvania, Forente stater, 18840
        • Rekruttering
        • Guthrie Foundation
        • Ta kontakt med:
        • Hovedetterforsker:
          • Rebekah Macfie
      • York, Pennsylvania, Forente stater, 17403
        • Rekruttering
        • Cancer Care Associates of York (CCAY)
        • Hovedetterforsker:
          • Chanh Huynh
        • Ta kontakt med:
    • Texas
      • Houston, Texas, Forente stater, 77030
        • Rekruttering
        • Onocology Consultants P.A. (Oncology Consultants [OC Houston])
        • Hovedetterforsker:
          • Julio Peguero
        • Ta kontakt med:
      • Kingwood, Texas, Forente stater, 77339
        • Rekruttering
        • Community Clinical Trials
        • Hovedetterforsker:
          • Saleha Sajid
        • Ta kontakt med:
      • Texarkana, Texas, Forente stater, 75503
    • Virginia
      • Richmond, Virginia, Forente stater, 23229
        • Rekruttering
        • Virginia Cancer Institute
        • Ta kontakt med:
        • Hovedetterforsker:
          • Susan Moore
    • Washington
      • Tacoma, Washington, Forente stater, 98405
        • Rekruttering
        • Northwest Medical Specialties (NWMS)
        • Ta kontakt med:
        • Hovedetterforsker:
          • Manas Agastya

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Study participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors

Beskrivelse

Eligibility Criteria:

  1. Age 18 years or older.

  2. Confirmed histological or cytological diagnosis of a malignant solid tumor that is either specified in one of the pre-defined tumor cohorts or meets the enrollment criteria for the Mix of Solid Tumors (MOST) cohort (Table 1).

  3. Eligible for curative intent therapy, with surgical resection of cancer planned.

    a. If surgical resection has occurred, enrollment should occur within 3 months of surgical resection and before initiation of adjuvant therapy.

  4. Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2.

  5. No systemic therapy for current cancer diagnosis administered before enrollment.

  6. Willing and able to comply with required study procedures, including blood sample collection and primary tumor tissue submission from diagnostic biopsy or surgical excision.

  7. Has completed all therapy (including endocrine therapy) 3 or more years ago for any previous invasive solid organ malignancy (with exception of nonmelanoma skin cancers) or hematologic malignancy. Individuals with a prior history of noninvasive (in situ) carcinomas may participate if they have received definitive treatment (no washout period required).

  8. No concurrent diagnosis of another invasive cancer, except for nonmelanoma skin cancers.

  9. No prior allogeneic hematopoietic stem cell transplant.

  10. Able and willing to provide informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information.

    Cohort Specific Criteria

  11. Muscle-invasive urothelial carcinoma of the bladder and Melanoma Cohorts: Stage II or operable III cancer:

  12. Esophageal, Gastric/GEJ, and NSCLC Cohorts: Stage I, II, or operable III cancer.

  13. Pancreatic Cohort: Stage I, II or operable III cancer, exocrine only disease.

  14. MOST cohort: Stage II or operable stage III solid tumor diagnosis that meets eligibility criteria and is not included in the other cohorts.

The following tumor types are excluded:

  1. Central nervous system (CNS) malignancies

  2. Colorectal cancer

  3. Breast cancer

  4. Squamous cell skin cancer

  5. Basal cell carcinoma

  6. Gastrointestinal stromal tumors (GIST)

  7. Thyroid cancer

  8. Uveal melanoma

  9. Low or intermediate grade neuroendocrine tumors

    ■ Eligible tumor types: High-grade neuroendocrine tumors, including neuroendocrine carcinomas, Merkel cell carcinomas, and small cell lung cancer are permissible

  10. Hematologic cancers including multiple myeloma or other plasma cell dyscrasias, Hodgkin's lymphoma, non-Hodgkin's lymphoma, acute or chronic leukemias including chronic lymphocytic leukemia / small lymphocytic leukemia

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Observasjonsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Muscle Invasive Urothelial Carcinoma of the Bladder (MIBC)

Muscle Invasive Urothelial Carcinoma of the Bladder (MIBC)

routine standard of care

Routine standard of care

Esophageal

Esophageal cancer

routine standard of care

Routine standard of care

Gastric and Gastroesophageal Junction (GEJ)

Gastric and Gastroesophageal Junction (GEJ)

routine standard of care

Routine standard of care

Melanoma

Melanoma

routine standard of care

Routine standard of care

Non-small cell lung (NSCLC)

Non-small cell lung (NSCLC)

routine standard of care

Routine standard of care

Pancreatic (exocrine only)

Pancreatic (exocrine only)

routine standard of care

Routine standard of care

Mix of Solid Tumors (MOST)

Mix of Solid Tumors (MOST)

routine standard of care

Routine standard of care

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Blood and tissue biospecimen registry
Tidsramme: Observation from enrollment to 5.5 years after enrollment

To establish a blood and tissue biospecimen resource in participants with operable solid tumors, with clinical, lab, radiographic, and pathology annotation for the discovery, development, and validation of MRD assays.

Observation from enrollment to 5.5 years after enrollment

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

8. januar 2025

Primær fullføring (Antatt)

1. desember 2031

Studiet fullført (Antatt)

1. april 2032

Datoer for studieregistrering

Først innsendt

18. september 2024

Først innsendt som oppfylte QC-kriteriene

18. september 2024

Først lagt ut (Faktiske)

20. september 2024

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

24. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

22. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere